Apogee Therapeutics, Inc. 10-K filing
Filed 2026-03-02 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0001974640-26-000002
- Form type
- 10-K
- CIK
- 0001974640
- Primary document
- https://www.sec.gov/Archives/edgar/data/1974640/000197464026000002/apge-20251231.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Apogee Therapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-285.6M | - | - |
| Net Income | $-255.8M | - | - |
| Eps Basic | -4.22 | - | - |
| Eps Diluted | -4.22 | - | - |
| Cash And Equivalents | $131.5M | - | - |
| Total Assets | $937.1M | - | - |
| Total Liabilities | $33.3M | - | - |
| Operating Cash Flow | $-227.4M | - | - |
| Capital Expenditures | $5.1M | - | - |